[1]
2024. Microvesicles from Mesenchymal Stem Cells Overexpressing MiR-34a Ameliorate Renal Fibrosis In Vivo. Iranian Journal of Kidney Diseases. 18, 2 (Apr. 2024), 99–107. DOI:https://doi.org/10.5254/s9bdqs74.